Virtu Financial’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Buy |
+46,760
| New | +$135K | 0.01% | 991 |
|
|
2024
Q4 | – | Sell |
-10,843
| Closed | -$71K | – | 1826 |
|
|
2024
Q3 | $71K | Buy |
+10,843
| New | +$71K | ﹤0.01% | 959 |
|
|
2024
Q2 | – | Sell |
-17,578
| Closed | -$133K | – | 1632 |
|
|
2024
Q1 | $133K | Buy |
+17,578
| New | +$133K | 0.01% | 875 |
|
|
2023
Q2 | – | Sell |
-32,185
| Closed | -$146K | – | 1806 |
|
|
2023
Q1 | $146K | Buy |
+32,185
| New | +$146K | 0.02% | 849 |
|
|
2019
Q4 | $117K | Buy |
+8,781
| New | +$117K | 0.01% | 1056 |
|
|
2019
Q3 | – | Sell |
-996
| Closed | -$14K | – | 1643 |
|
|
2019
Q2 | $14K | Buy |
+996
| New | +$14K | ﹤0.01% | 1356 |
|
|
2017
Q4 | – | Sell |
-1,572
| Closed | -$66K | – | 2720 |
|
|
2017
Q3 | $66K | Buy |
+1,572
| New | +$66K | ﹤0.01% | 2170 |
|